NDA, BLA Submissions Expected To Fall Again in FY 2011
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA estimates that the number of fee-paying applications will continue to decline, meaning the user fee itself will increase more than 19% to $1.842 million for applications requiring clinical data.